Anders Bengtsson Anaphylatoxin AB
ActiveKey figures
Key figures
2025Summary: Anders Bengtsson Anaphylatoxin AB
What kind of company is it?
Anders Bengtsson Anaphylatoxin AB (org. no. 556692-5201) is a limited company (AB). The company was registered in 2005 and has existed for 20 years. Registered seat: Kungsbacka.
How is the company doing financially?
The company had no net sales in financial year 2025. The company was profitable in 1 of the 6 reported financial years. According to the annual report, the company had no employees in financial year 2025. At the end of financial year 2025, total assets were 1 351 322 kr and equity 1 128 868 kr (equity ratio 83,5 %). The annual report for 2025 proposes a dividend of 322 400 kr.
Where does the data come from and how up to date is it?
Company details and digitally filed annual reports come from the open data of the Swedish Companies Registration Office (Bolagsverket) and the industry code from Statistics Sweden (CC BY 2.5 SE); bolagsprofil.se updates them daily. The latest annual report is signed by one person. Data as of 2026-11-16. Changes, averages and ratios are calculated by bolagsprofil.se from open data and are not an official assessment.
Dividend
from the annual reportProposed dividend 322 400 kr.
Summary of annual reports2019–2025
| 2020 | 2021 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|
| Sales revenue | 0 | 0 | 0 | 1 | 0 |
| Profit for the reporting year | −11 745 | −22 500 | −516 | 469 675 | 0 |
| Retained earnings of previous periods | — | — | — | — | — |
| Total assets | 1 922 194 | 1 496 429 | 1 282 646 | 1 351 322 | 1 351 322 |
| Total liabilities | 73 394 | 36 129 | 208 128 | 11 454 | 222 454 |
| Total equity | 1 848 800 | 1 460 300 | 1 074 518 | 1 339 868 | 1 128 868 |
| Employees | — | — | 0 | 0 | 0 |
| Proposed dividend | — | — | — | 211 000 | 322 400 |
A dash (—) means the report has not been filed or the line is not reported; 0 is a zero stated in the report.